Novozymes A/S Stock Forecast, Price & News

-0.77 (-1.06 %)
(As of 05/6/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume309 shs
Average Volume1,217 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive NVZMF News and Ratings via Email

Sign-up to receive the latest news and ratings for Novozymes A/S and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


See More Headlines
Novozymes A/S logo

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes and microorganisms in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America. The company offers agriculture solutions, including crop production, and animal health and nutrition solutions; liquefaction, saccharifaction, fermentation, cellulosic hydrolysis, and process enhancement solutions for bioenergy; baking, beverages, dairy, starch, and protein ingredients for the food and beverage industry; and laundry, dishwashing, and professional cleaning solutions for the household care industry. It also provides wastewater solutions, such as additives, biogas production, industrial bio cleaning, compound removal, odor control, and system start-up solutions; and textile solutions comprising denim abrasion and finishing, biopreparation, biopolishing bleach clean-up, and desizing solutions. In addition, the company offers forest products that include bleach boosting, deinking, fiber modification, effluent control, pitch and stickies control, and starch modification products; and leather solutions, which comprise biopreparation, degreasing, and re-bating. Further, it provides pharmaceutical solutions, including lipases, immobilized lipases, and proteases for biocatalysis; and rTrypsin for cell culture. Novozymes A/S has collaboration with FMC Corporation to co-develop enzyme solutions. The company is based in Bagsvaerd, Denmark.


Overall MarketRank

0.40 out of 5 stars

Medical Sector

1753rd out of 2,041 stocks

Biotechnology Industry

115th out of 157 stocks

Analyst Opinion: 0.0Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Novozymes A/S (OTCMKTS:NVZMF) Frequently Asked Questions

What stocks does MarketBeat like better than Novozymes A/S?

Wall Street analysts have given Novozymes A/S a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Novozymes A/S wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Novozymes A/S?

Novozymes A/S saw a increase in short interest in April. As of April 15th, there was short interest totaling 1,328,800 shares, an increase of 29.9% from the March 31st total of 1,022,900 shares. Based on an average trading volume of 900 shares, the days-to-cover ratio is presently 1,476.4 days.
View Novozymes A/S's Short Interest

How were Novozymes A/S's earnings last quarter?

Novozymes A/S (OTCMKTS:NVZMF) released its quarterly earnings data on Wednesday, April, 20th. The biotechnology company reported $0.37 earnings per share for the quarter, missing the consensus estimate of $2.43 by $2.06.
View Novozymes A/S's earnings history

How has Novozymes A/S's stock been impacted by Coronavirus (COVID-19)?

Novozymes A/S's stock was trading at $45.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, NVZMF shares have increased by 56.1% and is now trading at $71.65.
View which stocks have been most impacted by COVID-19

Who are Novozymes A/S's key executives?

Novozymes A/S's management team includes the following people:
  • Ms. Ester Baiget, Pres & CEO (Age 50, Pay $2.78M)
  • Mr. Lars Green M.Sc., MSc, Exec. VP & CFO (Age 54, Pay $1.79M)
  • Ms. Graziela Chaluppe dos Santos Malucelli, COO and Exec. VP of Operations, Supply & Quality (Age 48)
  • Mr. Tobias Cornelius Bjorklund, Head of Investor Relations
  • Mr. Tue Micheelsen, VP of Global Sales & Marketing
  • Mr. Morten Enggaard Rasmussen, Exec. VP of People, Sustainability & Brand
  • Mr. Pedro Luiz Fernandes, Head of Corp. Affairs & Sustainability - Novozymes Latin America
  • Mr. Anders Lund, Exec. VP of Consumer Biosolutions (Age 48)
  • Mr. Sebastian Søderberg, VP and Head of New Bus. Devel. - Incubations & Acquisitions
  • Ms. Tina Sejersgard Fano, Exec. VP of Agriculture & Industrial Biosolutions (Age 52)

Who are some of Novozymes A/S's key competitors?

What is Novozymes A/S's stock symbol?

Novozymes A/S trades on the OTCMKTS under the ticker symbol "NVZMF."

How do I buy shares of Novozymes A/S?

Shares of NVZMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novozymes A/S's stock price today?

One share of NVZMF stock can currently be purchased for approximately $71.65.

How many employees does Novozymes A/S have?

Novozymes A/S employs 6,274 workers across the globe.

What is Novozymes A/S's official website?

The official website for Novozymes A/S is www.novozymes.com.

Where are Novozymes A/S's headquarters?

Novozymes A/S is headquartered at Krogshoejvej 36, BAGSVAERD, 2880, Denmark.

How can I contact Novozymes A/S?

Novozymes A/S's mailing address is Krogshoejvej 36, BAGSVAERD, 2880, Denmark. The biotechnology company can be reached via phone at +45-44-460000.

This page was last updated on 5/7/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.